Delivery Order SPE2DB20D1100-SPE2DB24FC8H4
Award Date
7/19/24
Potential Completion Date
8/9/24
Potential Value
$3.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a pharmaceutical product, with a ceiling value of $3,581.62 and a performance period ending on May 23, 2025. The contract is a firm fixed-price, non-set-aside delivery order. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML. The delivery order is valued at $3,756.72 and has a firm fixed-price pricing structure. The ultimate completion date for this contract is August 27, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $3,721.90, is for the supply of HYPERRAB 300 UNIT/ML VIALML, a pharmaceutical product. The contract is a Firm Fixed Price arrangement with a completion date of October 28, 2024. This contract award is not associated with a set-aside program. As a major pharmaceutical distributor, AmerisourceBergen has been...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML medical products. The $11,031.48 firm fixed price contract has a completion date of March 24, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for the supply of HYPERRAB 300 UNIT/ML VIALML, a pharmaceutical product, with a ceiling value of $3,721.90. The contract is a firm fixed-price delivery order with a period of performance through November 1, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major supplier of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,386.04, is for the delivery of HYPERRAB 300 UNIT/ML VIALML, a medical product. The contract is a firm fixed-price agreement, with an ultimate completion date of April 8, 2025. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,261.69, is for the delivery of HYPERRAB 300 UNIT/ML VIALML, a medical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 27, 2023. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a medical product, with a ceiling value of $7,163.24. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is April 30, 2025. The contract is not designated with a set-aside requirement, indicating open...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of HYPERRAB 300 UNIT/ML VIALML. The firm-fixed-price contract has a ceiling value of $2,079.06 and an ultimate completion date of July 21, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp is a for-profit organization headquartered in Conshohocken,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,205.58, is for the delivery of HYPERRAB 300 UNIT/ML VIAL 3ML medical products. It is a firm fixed price contract with a completion date of July 15, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...